Works matching IS 00071048 AND DT 2007 AND VI 139 AND IP 3


Results: 27
    1

    Pralatrexate, a novel class of antifol with high affinity for the reduced folate carrier-type 1, produces marked complete and durable remissions in a diversity of chemotherapy refractory cases of T-cell lymphoma.

    Published in:
    British Journal of Haematology, 2007, v. 139, n. 3, p. 425, doi. 10.1111/j.1365-2141.2007.06658.x
    By:
    • Owen A. O'Connor;
    • Hamlin, Paul A.;
    • Portlock, Carol;
    • Moskowitz, Craig H.;
    • Noy, Ariela;
    • Straus, David J.;
    • MacGregor-Cortelli, Barbara;
    • Neylon, Ellen;
    • Sarasohn, Debra;
    • Dumetrescu, Otila;
    • Mould, Diane R.;
    • Fleischer, Martin;
    • Zelenetz, Andrew D.;
    • Sirotnak, Frank;
    • Horwitz, Steven
    Publication type:
    Article
    2

    Book review.

    Published in:
    2007
    By:
    • Stanworth, Simon
    Publication type:
    Book Review
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17

    High nerve growth factor receptor (p75NTR) expression is a favourable prognostic factor in paediatric B cell precursor-acute lymphoblastic leukaemia.

    Published in:
    British Journal of Haematology, 2007, v. 139, n. 3, p. 450, doi. 10.1111/j.1365-2141.2007.06818.x
    By:
    • Anja Troeger;
    • Gudowius, Sonja;
    • Escherich, Gabriele;
    • den Boer, Monique L.;
    • Glouchkova, Ludmila;
    • Ackermann, Birgit;
    • Meisel, Roland;
    • Laws, Hans-Juergen;
    • Groeger, Marketa;
    • Wessalowski, Ruediger;
    • Willers, Reinhart;
    • Harbott, Jochen;
    • Pieters, Rob;
    • Goebel, Ulrich;
    • Janka-Schaub, Gritta E.;
    • Hanenberg, Helmut;
    • Dilloo, Dagmar
    Publication type:
    Article
    18
    19
    20

    Influence of human leucocyte antigen disparity and graft lymphocytes on allogeneic engraftment and survival after umbilical cord blood transplant in adults.

    Published in:
    British Journal of Haematology, 2007, v. 139, n. 3, p. 464, doi. 10.1111/j.1365-2141.2007.06824.x
    By:
    • van Heeckeren, Willem J.;
    • Fanning, Laura R.;
    • Meyerson, Howard J.;
    • Pingfu Fu;
    • Lazarus, Hillard M.;
    • Cooper, Brenda W.;
    • Tse, William W.;
    • Kindwall-Keller, Tamila L.;
    • Jaroscak, Jennifer;
    • Finney, Marcie R.;
    • Fox, Robert M.;
    • Solchaga, Luis;
    • Forster, Margaret;
    • Creger, Richard J.;
    • Laughlin, Mary J.
    Publication type:
    Article
    21
    22
    23
    24
    25

    Phase I/II clinical trial of sequential subcutaneous and intravenous delivery of dendritic cell vaccination for refractory multiple myeloma using patient-specific tumour idiotype protein or idiotype (VDJ)-derived class I-restricted peptides.

    Published in:
    British Journal of Haematology, 2007, v. 139, n. 3, p. 415, doi. 10.1111/j.1365-2141.2007.06832.x
    By:
    • Curti, Antonio;
    • Tosi, Patrizia;
    • Comoli, Patrizia;
    • Terragna, Carolina;
    • Ferri, Elisa;
    • Cellini, Claudia;
    • Massaia, Massimo;
    • D'Addio, Alessandra;
    • Giudice, Valeria;
    • Di Bello, Cristiana;
    • Cavo, Michele;
    • Conte, Roberto;
    • Gugliotta, Gabriele;
    • Baccarani, Michele;
    • Lemoli, Roberto M.
    Publication type:
    Article
    26
    27